Solid Biosciences Inc logo

Solid Biosciences Inc

$ 6.67 -0.06 (-0.89%) 10:08 PM EST
P/E:
At Loss
P/B:
0.35
Market Cap:
$ 50.26M
Enterprise V:
$ -65.76M
Volume:
3.23K
Avg Vol (2M):
34.68K
Volume:
3.23K
Market Cap $:
50.26M
PE Ratio:
At Loss
Avg Vol (2-Month):
34.68K
Enterprise Value $:
-65.76M
PB Ratio:
0.35
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of speciality and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. Its lead product candidate, the SGT-001, is a gene transfer under development to restore functional dystrophin protein expression in patients' muscles. The company's pipeline products are the SB-001 and solid suit. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.
Name Current Vs Industry Vs History
Cash-To-Debt 5.53
Equity-to-Asset 0.78
Debt-to-Equity 0.18
Debt-to-EBITDA -0.3
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -4.11
Distress
Grey
Safe
Beneish M-Score -3.39
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 45.52
9-Day RSI 50.29
14-Day RSI 46.38
6-1 Month Momentum % -7.93
12-1 Month Momentum % -77.17

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 8.72
Quick Ratio 8.72
Cash Ratio 8.4
Days Sales Outstanding 8.15

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -46

Profitability Rank

Name Current Vs Industry Vs History
Operating Margin % -791.41
Net Margin % -795.16
ROE % -48.47
ROA % -41.33
ROIC % -300.66
ROC (Joel Greenblatt) % -478.47
ROCE % -45.63

Financials (Next Earnings Date:2023-03-14 Est.)

SLDB's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:SLDB

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 11.248
EPS (TTM) ($) -11.827
Beta 1.23
Volatility % 89.7
14-Day RSI 46.38
14-Day ATR ($) 0.382584
20-Day SMA ($) 6.492
12-1 Month Momentum % -77.17
52-Week Range ($) 5.8901 - 30.749999
Shares Outstanding (Mil) 7.53

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Solid Biosciences Inc Filings

Document Form Filing Date
No Filing Data

Solid Biosciences Inc Analysis

Share your research

Headlines

See More
No news.